| Market Cap | ₹2,898Cr |
| ROE | 11.57% |
| P/E Ratio(TTM) | 34.34 |
| EPS(TTM) | 9.01 |
| P/B Ratio | 3.97 |
| Dividend Yield | 0.12% |
| Industry P/E | 32.95 |
| Book Value | 77.88 |
| Debt to Equity | 0.44 |
| Face Value | 1 |
| Parent Organisation | Sms Pharmaceuticals |
| Managing Director | Sri. Ramesh Babu Potluri |
| Founded | 1987 |
| NSE Symbol | SMSPHARMA |
| FUND NAME | AUM(%) |
|---|---|
| Quant Small Cap Fund Direct Plan Growth | 0.20% |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Divi's Laboratories | NA (0.00%) | 67.22 | ||
| Neuland Laboratories | NA (0.00%) | 87.06 | ||
| Jubilant Pharmova | NA (0.00%) | 35.59 | ||
| Acutaas Chemicals | NA (0.00%) | 61.09 |